A patient with moderate obstructive lung disease due to asthma presents with bilateral wheezing, reduced peak expiratory flow rate, and decreased FEV1. The healthcare team is considering adjustments to her treatment plan. Which intervention should the nurse prioritize to address the acute exacerbation of asthma symptoms?

C) Administer a short course of oral corticosteroids

A) Increase the dosage of inhaled corticosteroid

B) Introduce a long-acting beta-agonist (LABA)

C) Administer a short course of oral corticosteroids

D) Start leukotriene receptor antagonist therapy

A patient with a history of asthma presents with decreased peak expiratory flow rate, bilateral wheezing, and reduced FEV1 on pulmonary function tests. The healthcare team is considering adjustments to her asthma management plan. Which intervention should the nurse prioritize to address the acute exacerbation and prevent further airway remodeling?

C) Start a short course of oral corticosteroids

A) Increase the dosage of inhaled corticosteroid

B) Introduce a long-acting beta-agonist (LABA)

C) Start a short course of oral corticosteroids

A patient with asthma has been started on a regimen of increased inhaled corticosteroids and a long-acting beta-agonist (LABA). The patient shows signs of improvement, but also experiences palpitations and mild tremors. Which of the following nursing interventions is most appropriate to address the side effects while maintaining asthma control?

C) Discuss with the healthcare provider the possibility of reducing the LABA dosage and adding a leukotriene receptor antagonist

A) Discontinue the LABA and increase the corticosteroid dose

B) Advise the patient to take the LABA with a meal to reduce side effects

C) Discuss with the healthcare provider the possibility of reducing the LABA dosage and adding a leukotriene receptor antagonist

D) Encourage the patient to increase physical activity to reduce side effects

A patient with asthma is being monitored after an adjustment in her treatment regimen, which includes an increased dose of inhaled corticosteroids and the addition of a long-acting beta-agonist (LABA). She reports mild tremors and palpitations. The healthcare team is considering a step-down approach. What is the most appropriate nursing intervention to address the patient's current symptoms and treatment plan?

B) Educate the patient about the potential side effects of LABA and reinforce the importance of adherence to the treatment plan.

A) Reduce the dose of inhaled corticosteroids to minimize side effects.

B) Educate the patient about the potential side effects of LABA and reinforce the importance of adherence to the treatment plan.

C) Discontinue the LABA immediately and switch to a short-acting beta-agonist.

D) Suggest the use of leukotriene receptor antagonists to replace both the inhaled corticosteroids and LABA.

A patient with asthma is experiencing increased wheezing and a decrease in oxygen saturation to 90%. Arterial blood gas analysis shows mild respiratory alkalosis and hypoxemia. The healthcare team considers starting a short course of oral corticosteroids. What is the primary rationale for adding oral corticosteroids to the patient's treatment plan?

B) To decrease airway inflammation that may not be controlled by inhaled medications

A) To provide immediate bronchodilation and relief of asthma symptoms

B) To decrease airway inflammation that may not be controlled by inhaled medications

C) To prevent future asthma exacerbations by increasing long-term lung function

D) To improve oxygenation by directly increasing respiratory drive

A patient with asthma presents with decreased oxygen saturation, increased respiratory rate, and audible wheezing despite ongoing treatment. Arterial blood gas analysis shows mild respiratory alkalosis and hypoxemia. In addition to adjusting bronchodilator therapy, which nursing intervention is most appropriate to address the underlying issue?

C) Encourage the patient to perform pursed-lip breathing

A) Administer supplemental oxygen via nasal cannula

B) Educate the patient on stress management techniques

C) Encourage the patient to perform pursed-lip breathing

D) Initiate a high-protein diet to improve respiratory muscle function

A patient with asthma is being monitored after starting oral corticosteroids. Despite some improvement in peak flow readings and a slight increase in PaO2, the patient continues to experience dyspnea, chest tightness, and has an oxygen saturation of 92%. Which of the following nursing interventions should be prioritized to address the patient's respiratory distress?

C) Administer supplemental oxygen to maintain saturation above 94%

A) Increase the frequency of bronchodilator administration

B) Encourage the patient to perform pursed-lip breathing techniques

C) Administer supplemental oxygen to maintain saturation above 94%

D) Initiate a high-calorie, high-protein diet to support respiratory function

A patient with asthma is being monitored for response to oral corticosteroids and bronchodilators. Her peak flow readings show slight improvement, but she still experiences dyspnea, wheezing, and chest tightness. Her respiratory rate is 24 breaths per minute, and her oxygen saturation is 92%. Which of the following nursing interventions is the most appropriate to address her current clinical condition?

A) Increase the frequency of bronchodilator treatments and monitor the patient's peak flow readings.

B) Encourage the patient to perform breathing exercises and reassess her oxygen saturation.

C) Administer supplemental oxygen to maintain oxygen saturation above 95%.

D) Educate the patient on the importance of avoiding exertion until symptoms improve.

A 45-year-old female patient with asthma is experiencing an improvement in her peak flow readings and arterial blood gases but reports a new onset of nocturnal cough and increased dyspnea during routine activities. Her current treatment includes bronchodilators and inhaled corticosteroids. Based on the case details, which additional intervention should the nurse anticipate to further optimize her asthma management?

B) Add a leukotriene receptor antagonist to her regimen

A) Increase the dosage of inhaled corticosteroids

B) Add a leukotriene receptor antagonist to her regimen

C) Begin a course of oral corticosteroids

D) Initiate oxygen therapy at 2 L/min via nasal cannula

A patient with asthma shows improvement in peak flow readings and arterial blood gases but reports a new onset of nocturnal cough and increased dyspnea during activities. Her PaCO2 remains low, and her eosinophil count is elevated. Which nursing intervention should be prioritized based on this clinical picture?

C) Monitor the patient's response to the addition of a leukotriene receptor antagonist.

A) Educate the patient on proper use of rescue inhalers to manage nocturnal symptoms.

B) Encourage the patient to increase physical activity to improve lung function.

C) Monitor the patient's response to the addition of a leukotriene receptor antagonist.

D) Advise the patient to use a humidifier to reduce nighttime cough.

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - In asthma, chronic inflammation leads to swelling and increased mucus production in the airways, which causes narrowing and obstruction. Inflammatory cells like eosinophils and T-lymphocytes release mediators that sustain the inflammatory response and contribute to symptoms like wheezing and shortness of breath.

• Secondary mechanism: Bronchial hyperresponsiveness - The inflamed airways become overly sensitive to various triggers (e.g., allergens, exercise, cold air), resulting in bronchospasm. This is a sudden constriction of the muscles surrounding the airways, leading to further narrowing and airflow limitation.

• Key complication: Airway remodeling - Chronic inflammation and repeated asthma attacks can lead to structural changes in the airways, such as thickening of the airway walls. This may result in decreased lung function over time and can complicate disease management.

Patient Profile

Demographics:

35-year-old female, elementary school teacher

History:

• Key past medical history: Diagnosed with asthma at age 15, history of seasonal allergies, occasional bouts of bronchitis

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler twice daily, Loratadine 10 mg once daily

• Allergies: Penicillin, dust mites

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, fatigue, difficulty performing physical activities

• Vital signs: Blood pressure 130/85 mmHg, heart rate 102 bpm, respiratory rate 22 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F (37°C)

Section 1

As the healthcare team conducts an initial assessment of the patient, several findings raise concerns about the progression of her asthma. Upon auscultation, bilateral wheezing is heard, predominantly during expiration, indicating significant airway narrowing. Her peak expiratory flow rate (PEFR) is measured at 250 L/min, which is notably lower than her personal best of 400 L/min, suggesting a marked decrease in lung function. Additionally, the patient reports a persistent cough that is dry and hacking, which intensifies at night, often disrupting her sleep. These symptoms, combined with her increased respiratory rate and reduced oxygen saturation, highlight a possible exacerbation of her asthma, likely triggered by recent exposure to seasonal allergens or a viral upper respiratory infection.

In response to these findings, the healthcare team decides to order a chest X-ray and conduct pulmonary function tests (PFTs) to evaluate the extent of airway obstruction and rule out other potential complications, such as pneumonia or pneumothorax. The chest X-ray returns normal, with no signs of infection or structural abnormalities. However, the PFTs reveal a significant reduction in the Forced Expiratory Volume in one second (FEV1), which is at 60% of the predicted value, confirming the presence of moderate obstructive lung disease. This data points to the need for an adjustment in her asthma management plan, particularly focusing on reducing inflammation and preventing further airway remodeling.

Given this scenario, the healthcare team discusses potential changes to her treatment regimen. They consider increasing the dosage of her inhaled corticosteroid or introducing a long-acting beta-agonist (LABA) to improve her respiratory status. Additionally, given her fatigue and difficulty performing daily activities, a short course of oral corticosteroids may be warranted to quickly address the acute inflammation. The patient's response to these interventions will be closely monitored, focusing on improvements in her peak flow measurements, symptom relief, and overall quality of life. This approach aims not only to manage the current exacerbation but also to prevent future complications and maintain optimal lung function.

Section 2

Following the initiation of the adjusted treatment regimen, the healthcare team carefully monitors the patient's response to the interventions. Within 48 hours of starting the increased dose of inhaled corticosteroids and the addition of a long-acting beta-agonist (LABA), the patient exhibits some signs of improvement. Her peak expiratory flow rate (PEFR) has gradually increased to 320 L/min, reflecting a partial recovery towards her personal best. Additionally, her nocturnal cough has diminished, allowing her to achieve more restful sleep. However, her oxygen saturation remains slightly reduced at 92%, and her respiratory rate is still on the higher side at 24 breaths per minute, indicating that while the inflammation may be decreasing, airway narrowing persists.

Despite these improvements, new complications arise. The patient begins to complain of palpitations and mild tremors, which could be attributed to the LABA. This prompts the team to reassess the balance between therapeutic benefits and side effects. A review of her medication schedule and possible interactions is conducted, considering her entire pharmacological profile. The healthcare team contemplates using a step-down approach, reducing the LABA dosage while ensuring the patient continues to receive adequate anti-inflammatory treatment.

Given the persistence of certain symptoms and the emergence of side effects, the clinical reasoning process leads to a discussion on alternative therapies. The team considers incorporating leukotriene receptor antagonists to further manage inflammation and bronchoconstriction. They also emphasize the importance of environmental control, advising the patient to minimize exposure to known allergens and potential irritants. Education on adherence to the asthma action plan is reinforced, with an emphasis on recognizing early signs of exacerbation. The team schedules a follow-up appointment to closely monitor her progress and make necessary adjustments, aiming to stabilize her condition and prevent further complications.

Section 3

As the patient continues her treatment regimen, the healthcare team closely monitors her response to the interventions. During follow-up observations, the patient reports a significant decrease in the frequency of palpitations and tremors after the LABA dosage was adjusted. However, the team notes a concerning change in her status: the patient's oxygen saturation has decreased further to 90%, and she presents with audible wheezing upon auscultation. Her respiratory rate has increased to 26 breaths per minute, suggesting a potential exacerbation of her asthma symptoms despite ongoing treatment.

The team orders a series of diagnostic tests to gain a clearer understanding of her current condition. Arterial blood gas analysis reveals mild respiratory alkalosis with a pH of 7.48, indicating possible hyperventilation, and a partial pressure of oxygen (PaO2) of 60 mmHg, confirming hypoxemia. Additionally, a chest X-ray is performed to rule out any secondary complications, such as pneumonia or pneumothorax, and shows no acute infiltrates or structural abnormalities. These results prompt the team to reconsider the current management plan, focusing on optimizing her bronchodilator therapy and ensuring effective use of inhalers.

Given the persistence of her symptoms and the new diagnostic findings, the clinical reasoning process leads to a multidisciplinary discussion. The team decides to trial a short course of oral corticosteroids to address potential underlying inflammation that may not be fully controlled by inhaled medications. Education on correct inhaler technique is reinforced to ensure maximum drug delivery, and a peak flow meter is provided for daily monitoring at home. The team establishes a clear plan for reassessment within the next 48 hours, with the aim of preventing further deterioration and adjusting the treatment plan as needed to achieve optimal control of her asthma.

Section 4

In the next 48 hours, the patient is closely monitored for her response to the newly introduced oral corticosteroids, alongside her ongoing bronchodilator regimen. During this period, her daily peak flow readings reveal a slight upward trend, indicating some improvement in her airway function, yet her clinical presentation remains mixed. Notably, her wheezing persists, though it has become less pronounced compared to previous assessments. However, the patient still reports episodes of dyspnea and a persistent feeling of chest tightness, particularly during exertion.

In terms of vital signs, her respiratory rate remains elevated at 24 breaths per minute, suggesting ongoing respiratory distress, albeit slightly improved from her previous rate. Repeat arterial blood gas analysis shows a slight improvement in her PaO2, now at 65 mmHg, though it continues to reflect mild hypoxemia. Her pH has normalized to 7.44, which indicates that the hyperventilation is less severe, but still present. Despite these modest improvements, the team recognizes that the patient's oxygen saturation remains suboptimal, hovering around 92%, which warrants further investigation.

Given these findings, the team decides to extend the corticosteroid course for an additional few days while re-evaluating her bronchodilator regimen, considering the addition of a leukotriene receptor antagonist to further address airway inflammation. A referral to a pulmonologist is also considered for specialized assessment and management, especially if her condition does not show significant improvement. The focus remains on preventing potential complications, such as respiratory failure, by ensuring a comprehensive and proactive approach to her ongoing asthma management. The team plans for another reassessment within 72 hours to determine the effectiveness of the adjusted treatment plan and to decide on further interventions if necessary.

Section 5

Three days after the adjustment to her treatment plan, the patient presents with a mixed clinical picture that requires careful analysis. Her peak flow readings continue to show a gradual improvement, now consistently reaching 85% of her predicted values. However, while her wheezing has diminished significantly, she reports a new onset of nocturnal cough and an increased frequency of dyspnea episodes during routine activities. This suggests that her asthma control, while better, remains suboptimal.

New diagnostic results reveal an improvement in her arterial blood gases, with PaO2 rising to 70 mmHg and oxygen saturation improving slightly to 94%. Despite these positive changes, her PaCO2 remains on the lower side at 35 mmHg, indicating ongoing compensatory hyperventilation. A complete blood count shows an elevated eosinophil count, suggesting persistent allergic inflammation that might not be completely addressed by her current treatment. This finding supports the consideration of adding a leukotriene receptor antagonist to her regimen to target underlying inflammatory pathways more effectively.

As the team deliberates on the next steps, they note her vital signs: a respiratory rate of 22 breaths per minute and a heart rate of 98 beats per minute. These observations indicate some improvement in her respiratory distress, yet her symptoms and lab results highlight the need for a more tailored approach. The pulmonologist's input becomes crucial in refining her treatment plan, emphasizing the importance of a multidisciplinary approach to prevent potential complications. The decision is made to proceed with the referral and to continue monitoring her closely, with a follow-up scheduled in 72 hours to reassess her response to the interventions and to determine if further adjustments are necessary.